Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging. | Biomedicines | 2021 | 34356874 | PubTator, text mining | PubMed |
Integrating Bioinformatic Strategies with Real-World Data to Infer Distinctive Immunocyte Infiltration Landscape and Immunologically Relevant Transcriptome Fingerprints in Ossification of Ligamentum Flavum. | J Inflamm Res | 2021 | 34354364 | PubTator, text mining | PubMed |
| Cisplatin chemotherapy and renal function. | Adv Cancer Res | 2021 | 34353441 | PubTator, text mining | PubMed |
| Current Understanding of Membrane Transporters as Regulators or Targets for Cisplatin-Induced Hearing Loss. | Mol Pharmacol | 2021 | 34330821 | PubTator, text mining | PubMed |
| Quantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin Disposition. | Drug Metab Dispos | 2021 | 34330717 | PubTator, text mining | PubMed |
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study. | CNS Drugs | 2021 | 34322853 | PubTator, text mining | PubMed |
| Synthesis and Bioinformatic Characterization of New Schiff Bases with Possible Applicability in Brain Disorders. | Molecules | 2021 | 34299440 | PubTator, text mining | PubMed |
| Deregulation of Transcriptional Enhancers in Cancer. | Cancers (Basel) | 2021 | 34298745 | PubTator, text mining | PubMed |
| Organic Cation Transporters in Psychiatric Disorders. | Handb Exp Pharmacol | 2021 | 34282486 | PubTator, text mining | PubMed |
| Multistep rational molecular design and combined docking for discovery of novel classes of inhibitors of SARS-CoV-2 main protease 3CLpro. | Chem Phys Lett | 2021 | 34276059 | PubTator, text mining | PubMed |
| Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors. | Eur J Drug Metab Pharmacokinet | 2021 | 34275128 | PubTator, text mining | PubMed |
| Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan. | Adv Ther | 2021 | 34275116 | PubTator, text mining | PubMed |
| Prediction of the drug-drug interaction potential of the α1-acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib. | CPT Pharmacometrics Syst Pharmacol | 2021 | 34273250 | PubTator, text mining | PubMed |
| Oral and intravenous pharmacokinetics of metformin with and without oral codeine intake in healthy subjects: A cross-over study. | Clin Transl Sci | 2021 | 34268884 | PubTator, text mining | PubMed |
L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity. | Toxicology | 2021 | 34252480 | PubTator, text mining | PubMed |
| A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm. | Front Immunol | 2021 | 34248936 | PubTator, text mining | PubMed |
| Myopia in African Americans Is Significantly Linked to Chromosome 7p15.2-14.2. | Invest Ophthalmol Vis Sci | 2021 | 34241624 | PubTator, text mining | PubMed |
| Transcriptomic and epigenomic profiling of young and aged spermatogonial stem cells reveals molecular targets regulating differentiation. | PLoS Genet | 2021 | 34237055 | PubTator, text mining | PubMed |
| Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents. | Kidney Res Clin Pract | 2021 | 34233435 | PubTator, text mining | PubMed |
| Admixture Has Shaped Romani Genetic Diversity in Clinically Relevant Variants. | Front Genet | 2021 | 34220960 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=38